The First Experience of Cytokine Adsorption in the Patient with Sepsis after Cardiosurgical Procedure

D.L. Shukevich1, 2, G.P. Plotnikov1, M.S. Rubtsov1, V.G. Matveeva1, E.V. Grigoryev1, 2

1Scientific research institute for complex issues of cardiovascular diseases, Kemerovo

2Kemerovo State Medical University, Kemerovo

For correspondence: Grigoryev Evgeny — PhD, MD, Kemerovo; e-mail: grigev@kemcardio.ru

For citation: Shukevich DL, Plotnikov GP, Rubtsov MS, Matveeva VG, Grigoryev EV. The First Experience of Cytokine Adsorption in the Patient with Sepsis after Cardiosurgical Procedure. Intensive Care Herald. 2016;4:59–61.


Systemic inflammatory response is the basic for the host response against infectious and noninfectious agents. Cytokines are the leading mediators of the systemic inflammation. In patients with sepsis reduction of cytokines production may be useful to decrease the severity of the systemic inflammatory response and to ameliorate the multiorgan failure. We produce the case report — the successful experience of the intensive care of the septic patient after cardiac surgery with the help of cytokine adsorption. The normalization of hemodynamic status, the reduction of the SOFA scale and the decrease of the level of interleukin 6 confirmed the effectiveness of adsorption.

Keywords: systemic inflammatory response, sepsis, cytokine adsorption

Received: 07.10.2016


References

  1. Rimmelee T., Kellum J.A. Clinical review: blood purification for sepsis. Crit. Care. 2011; 15(1): 205. doi: 10.1186/cc9411.
  2. Cole L., Bellomo R., Journois D. et al. High-volume haemofiltration in human septic shock. Intensive Care Med. 2001; 27(6): 978–986. doi: 10.1007/s001340100963.
  3. Бердников А.П., Мусаева Т.С., Гончаренко С.И. Оценка эффективности комбинированного применения селективной липополисахаридной гемосорбции у больных с тяжелым сепсисом. Вестник интенсивной терапии. 2016; 5: 66–69. [Berdnikov A.P., Musaeva T.S., Goncharenko S.I. Evaluation of the effectiveness of the combined use of selective lipopolysaccharide hemosorption in patients with severe sepsis. Vestnik intensivnoy terapii. 2016; 5: 66–69. (In Russ)]
  4. Барбараш Л.С., Плотников Г.П., Шукевич Д.Л., Григорьев Е.В., Шукевич Л.Е. Гемодинамика и гидродинамический статус при системном воспалительном ответе инфекционной и неинфекционной этиологии на фоне продолжительной заместительной почечной терапии. Патология кровообращения и кардиохирургия. 2010; 4: 42–45. [Barbarash L.S., Plotnikov G.P., Shukevich D.L., Grigoryev E.V., Shukevich L.E. Hemodynamic and hydrodynamic status in the infectious and noninfectious systemic inflammatory response during continuous renal replacement therapy. Patologiya krovoobrascheniya i kardiohirurgiya. 2010; 4: 42–45. (In Russ)]
  5. Heering P., Morgera S., Schmitz F.J. et al. Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration. Intensive Care Med. 1997; 23(3): 288–296.
  6. Abraham E., Wunderink R., Silverman H. et al. Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group. 1995; 273(12): 934–941. doi: 10.1001/jama.1995.03520360048038.
  7. Peng Z.Y., Carter M.J., Kellum J.A. Effects of hemoadsorption on cytokine removal and short-term survival in septic rats. Crit. Care Med. 2008; 36(5): 1573–1577. doi: 10.1097/CCM.0b013e318170b9a7.
  8. Peng Z.Y., Wang H.Z., Carter M.J. et al. Acute removal of common sepsis mediators does not explain the effects of extracorporeal blood purification in experimental sepsis. Kidney Int. 2012; 81(4): 363–369. doi:1038/ki.2011.320.
  9. Hetz H., Berger R., Recknagel P., Steltzer H. Septic shock secondary to b-hemolytic streptococcus-induced necrotizing fasciitis treated with a novel cytokine adsorption therapy. Int. J. Artif. Organs. 2014; 37(5): 422–426. doi: 10.5301/ijao.5000315.
  10. Trager K., Fritzler D., Fischer G. et al. Treatment of post-cardiopulmonary bypass SIRS by hemoadsorption: a case series. Int. J. Artif. Organs. 2016; 39(3): 141–146. doi: 10.5301/ijao.5000492.
  11. Tomescu D.R., Olimpia Dima S., Ungureanu D. et al. First report of cytokine removal using CytoSorb in severe non-infectious inflammatory syndrome after liver transplantation. Int. J. Artif. Organs. 2016; 39(3): 136–140. doi: 10.5301/ijao.5000489.
  12. Gehling M., Tryba M. Is the time ripe for CytoSorb? Dtsch. Med. Wochenschr. 2016; 141(6): 428–429. doi: 10.1055/s-0041-110419.